Early short-term antiretroviral treatment may benefit HIV-positive babies

08/21/2013 | HealthDay News

Researchers monitored 377 HIV-positive babies for five years and found that those who completed the immediate 96-week antiretroviral treatment were able to avoid restarting the therapy for an average of 70 weeks. Waiting for symptoms to emerge before getting the treatment was linked to substantially higher rates of deaths and hospital admissions as well as greater medical costs than the immediate, temporary treatment. The findings appear in The Lancet.

View Full Article in:

HealthDay News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Assistant General Counsel, Regulatory
Cardinal Health
Waukegan, IL
Chief Executive Officer
UCare Minnesota
Minneapolis, MN